Morphic Holding stock was surging Monday after pharmaceutical giant Eli Lilly agreed to acquire the biopharmaceutical company ...
Eli Lilly agreed to buy Waltham-based gut-drug maker Morphic Holding Inc. for about $3.2 billion, plowing some of the ...
Eli Lilly acquires Morphic Holding for $3.2 billion, gaining a potential IBD treatment asset, MORF-057. Explore more details ...
Eli Lilly on Monday announced a $3.2 billion all-cash deal to purchase Morphic and its pipeline of oral integrin therapies in ...
The deal would hand Lilly an experimental pill that could one day rival Takeda's blockbuster medicine Entyvio as a treatment for inflammatory bowel disease.
Eli Lilly N/A will acquire Morphic Holding N/A for $3.2-billion in cash, the companies said on Monday, giving the U.S.
Eli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on Monday, beefing up its portfolio of ...
Eli Lilly says it will acquire a Waltham-based drug company that's working on a treatment for inflammatory bowel disease.
Morphic only had eyes for Eli Lilly. While some takeover tales have casts of Shakespearean breadth, Lilly’s $3.2 billion ...
Eli Lilly & Co. has announced the acquisition of Morphic Holding Inc., a US-based biotech company specializing in treatments ...
Eli Lilly & Co. acordó comprar Morphic Holding Inc., fabricante estadounidense de fármacos para el intestino, por alrededor ...
It was a mating dance that lasted more than three years. At the end, Eli Lilly and Co. wound up buying a Massachusetts-based ...